Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome

Yi‐Jun Xue(Guangdong Medical College), Haiwen Huang(Second Affiliated Hospital of Soochow University)
Journal of Experimental & Clinical Cancer Research
August 27, 2019
10.1186/s13046-019-1386-6
Cited by 27

Related Papers

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial
|Advances in Therapy|2021|19
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study
|American Journal of Hematology|2023|18
Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression
|Molecular Medicine Reports|2014|13
Role of epithelial-to-mesenchymal transition in the pulmonary fibrosis induced by paraquat in rats
|World Journal of Emergency Medicine|2021|7